Crossmark

Changes of N6-methyladenosine modulators promote breast cancer progression

Crossref DOI link: https://doi.org/10.1186/s12885-019-5538-z

Published Online: 2019-04-05

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Lianpin

Wu, Dengying

Ning, Jinfeng

Liu, Wei

Zhang, Donghong
License Information

Text and Data Mining valid from 2019-04-05
More Information

Article History

Received: 7 May 2018

Accepted: 28 March 2019

First Online: 5 April 2019

Ethics approval and consent to participate

: The use of clinical samples in our study was according to the Declaration of Helsinki and was approved by the Ethics Committee of the Second Affiliated Hospital of Wenzhou Medical University in Sept. 2017 (Number:L-2017-05). Written informed consent was obtained from each participant.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.